Cis-4-Hydroxy-Lomustine | CAS 52049-26-0 - Request Quote
Cis-4-Hydroxy-Lomustine
| SZ CAT No: | SZ-L116006 |
| CAS No | 52049-26-0 |
| Mol.F. | C9H16ClN3O3 |
| Mol.Wt. | 249.7 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cis-4-Hydroxy-Lomustine is chemically 1-(2-Chloroethyl)-3-((1s,4s)-4-hydroxycyclohexyl)-1-nitrosourea. Cis-4-Hydroxy-Lomustine is supplied with detailed characterization data compliant with regulatory guideline. Cis-4-Hydroxy-Lomustine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lomustine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 52049-26-0
Purchase 52049-26-0
Order 52049-26-0
Enquire 52049-26-0
price of 52049-26-0
52049-26-0 Supplier
52049-26-0 Manufacturer
52049-26-0 Exporter
buy high quality Cis-4-Hydroxy-Lomustine
Purchase Cis-4-Hydroxy-Lomustine
Cis-4-Hydroxy-Lomustine suppliers
Cis-4-Hydroxy-Lomustine manufacturers
Cis-4-Hydroxy-Lomustine price
Order Cis-4-Hydroxy-Lomustine
Enquire Cis-4-Hydroxy-Lomustine
Cis-4-Hydroxy-Lomustine cost
Cis-4-Hydroxy-Lomustine Supplier
Cis-4-Hydroxy-Lomustine Distributor
Cis-4-Hydroxy-Lomustine for Method Validation
Lomustine Reference Standard
Cis-4-Hydroxy-Lomustine for ANDA Filing
Cis-4-Hydroxy-Lomustine for Forced Degradation Studies
Cis-4-Hydroxy-Lomustine Identification Standards
Cis-4-Hydroxy-Lomustine for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


